MedPath

A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients

Not Applicable
Completed
Conditions
Asthma
Interventions
Behavioral: Intervention Group
Registration Number
NCT00195117
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The primary objective of this randomized trial is to evaluate a novel intervention of induced positive affect and induced self-affirmation to increase physical activity in patients with asthma.

Detailed Description

The primary objective of this randomized trial is to evaluate a novel intervention of induced positive affect and induced self-affirmation to increase physical activity in patients with asthma. At the start of the trial all patients in conjunction with their physicians will select a program of mild to moderate physical activity or exercise to be adopted and maintained on a routine basis. All patients will record perceived exertion and pedometer measurements in a log diary. All patients will be contacted by telephone at set time intervals to encourage them to continue their selected physical activity or exercise. Patients randomized to the intervention arm will also receive induced positive affect and self-affirmation throughout the study period. Patients in the control arm will not receive the positive affect and self-affirmation components.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
258
Inclusion Criteria

Patients will be eligible for this study

  • if their physicians consider them medically able to participate, if they are 18 years of age or older
  • if they have a diagnosis of mild to moderate asthma based on the NHLBI Asthma Expert Panel's classification system which rates symptoms, frequency of exacerbations, nocturnal attacks, activity restriction, use of medications, and pulmonary function.
Read More
Exclusion Criteria

Patients will be excluded from this study for the following reasons:

  • If they are unable to walk several blocks for whatever reason;
  • If they have musculoskeletal or neurological deficits that preclude increased physical activity;
  • If they have other pulmonary diseases;
  • If they have cardiac disease or other severe comorbidity;
  • If they are unable to provide informed consent because of cognitive deficits;
  • If they refuse to participate.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupIntervention GroupThis group received follow-up every 2-months for one year. Follow-up included questions about their asthma and how well they had been able to engage in their doctor approved physical activity goal, which was the same as the control arm. Additionally, subjects in this arm were encouraged to use positive affect and self-affirmation techniques to motivate an increased level of participation in their physical activity goal. These subjects also received small token gifts to remind them of their participation in this study.
Primary Outcome Measures
NameTimeMethod
The primary outcome will be change in Paffenbarger Physical Activity and Exercise Index scores from enrollment to 12 months.every 2 months for 1 year
Secondary Outcome Measures
NameTimeMethod
Pedometer readings from enrollment to 12 months.every 2 months for 1 year
Change in asthma status measured by the Asthma Control Questionnaire from enrollment to 12 months.baseline and one year after enrollment at closeout
Change in quality of life measured by the Asthma Quality of Life Questionnaire enrollment to 12 months.at baseline, 4-,8-month follow-ups and one year after enrollment at closeout
Changes in the SF-12 from enrollment to 12 months.baseline and one year after enrollment at closeout

Trial Locations

Locations (1)

New York Presbyterian Hospital-Weill Medical College of Cornell University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath